cardiovascular outcomes glp-1 news today disease continuum-GLP-1 action. Adapted from [46] The GLP-1 revolution is here

Patients seeking non-invasive skin firming : Especially those wanting to avoid more aggressive procedures or who are not candidates for surgery

Phase 2 Side-Effect Frequencies at 4.5 mg/week (Lancet 2021) Side Effect Nausea Incidence at 4.5 mg/week 47% Side Effect Injection-site reactions Incidence at 4.5 mg/week 43% Side Effect Constipation Incidence at 4.5 mg/week 21% Side Effect Fatigue Incidence at 4.5 mg/week 20% Side Effect Allergic reactions (any) Incidence at 4.5 mg/week 10% Side Effect Vomiting Incidence at 4.5 mg/week 8% Side Effect Loose stools Incidence at 4.5 mg/week 7% Side Effect Headache Incidence at 4.5 mg/week 7% Side Effect Indigestion Incidence at 4.5 mg/week 4% Incidence was lower at lower doses

The study highlights that those experiencing fewer side effects are less likely to quit, emphasizing the impact of tolerability and affordability on long-term use

How natural and how processed is it